🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hematological Malignancies

Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue NCT06482515Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Time-restricted eating, Nutrition counseling Increasing Knowledge and Interest in Cancer Clinical Trials NCT06501040NA1 site📍 Detroit Hayley Thompson · Tests: Web-based Educational Intervention, Questionnaire Administration Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) NCT07445984NA1 site📍 Parma Azienda Ospedaliero-Universitaria di Parma · Tests: Genetic, molecular and/or omics analyses CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies NCT07106749Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: CD180 CART A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies NCT05908409Phase 1, Phase 211 sites📍 Santander📍 Salamanca📍 Barcelona IDP Discovery Pharma S.L. · Tests: IDP-121 Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms NCT06063486Phase 22 sites📍 Los Angeles📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-co… A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor NCT06615193Phase 18 sites📍 Zhengzhou📍 Suzhou📍 Suzhou Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Tests: HDM2005 IVIG for Infection Prevention After CAR-T-Cell Therapy NCT05952804Phase 27 sites📍 Duarte📍 Miami📍 Tampa Fred Hutchinson Cancer Center · Tests: Immune Globulin Infusion (Human), 10% Solution, Anti-CD19 CAR T Cells Preparation, Saline, Biospecimen Collection, Surv… Immune Profiling for Cancer Immunotherapy Response NCT06116032n/a1 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: Methylation Cytometry Asian Myeloproliferative Neoplasm (MPN) Registry NCT05882773n/a1 site📍 Hong Kong The University of Hong Kong An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies NCT07101705EARLY Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: OriV508 Injection A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) NCT06782373Phase 239 sites📍 Scottsdale📍 Boston📍 Rochester Swedish Orphan Biovitrum · Tests: Pacritinib, Placebo Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography A Clinical Study of HMPL-506 in Patients With Hematological Malignancies NCT06387082Phase 116 sites📍 Changsha📍 Chongqing📍 Fuzhou Hutchmed · Tests: HMPL-506 Cord Blood Transplantation in Children and Young Adults With Blood Cancer NCT07566377Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Cord Blood Units, Total Body Irradiation, Cyclophosphamide, Fludarabine, Clofarabine Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant NCT07709195Phase 21 site📍 Navi Mumbai Tata Memorial Centre · Tests: Sodium Copper Chlorophyllin Study of INCA036978 in Participants With Myeloproliferative Neoplasms NCT07441694Phase 154 sites📍 Birmingham📍 Irvine📍 Los Angeles Incyte Corporation · Tests: INCA036978, Standard disease-directed therapy Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis NCT06699394NA2 sites📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Teclistamab (Tec) MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera NCT04116502Phase 355 sites📍 Aberdeen📍 Bath📍 Belfast University of Birmingham · Tests: Ruxolitinib, Hydroxycarbamide, Interferon-Alpha Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer NCT06503380n/a1 site📍 Shanghai Fudan University · Tests: No intervenrion. Allo HSCT Using RIC and PTCy for Hematological Diseases NCT05805605Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Peripheral Blood Stem Cell Transplant, Allopurinol 300 MG, Fludarabine, Cyclophosphamide, Bone Marrow Cell Transplant Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies NCT05887167Phase 11 site📍 Los Angeles Joshua Sasine, MD, PhD · Tests: autologous hematopoietic stem cells added to planned CAR T Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) NCT06469307NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: DIVERSE Review Process Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) NCT03486873Phase 3782 sites📍 Tucson📍 Bakersfield📍 Fresno Merck Sharp & Dohme LLC · Tests: Pembrolizumab, Standard of Care (SOC), Lenvatinib, Olaparib, MK-4280 Halt Aging in Survivors of Blood Cancers NCT07292272NA1 site📍 Omaha University of Nebraska · Tests: Behavioral Coaching Intervention, Virtual Exercise Platform Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies NCT06037018Phase 11 site📍 Tianjin CytoCares Inc · Tests: CC312 Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies NCT06904066Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: aldesleukin, cyclophosphamide, fludarabine phosphate, Individual Patient TCR-Transduced PBL, TruSight Oncology (TSO) 500 Implementation of an Oral Chemotherapy Adherence Intervention NCT06989489NA1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Multilevel Adherence Intervention Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure NCT04905810Phase 24 sites📍 Clovis📍 Los Angeles📍 Sacramento Brian Jonas · Tests: Azacitidine, Decitabine, Venetoclax 18F-Pentixafor PET in Hematologic Malignancies NCT07122674n/a1 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: 18F-Pentixafor
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy